Eyeing 2013 Launch of Mass Spec Preterm Birth Test, Sera Closes $19.3M Round, Names Critchfield CEO | GenomeWeb

This story originally ran on Nov. 15.

By Adam Bonislawski

Sera Prognostics said this week that it has closed a $19.3 million Series A financing round and appointed former Myriad Genetics president Gregory Critchfield as its new CEO.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.